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Importance of Meta-analyses 
for Evaluating Carcinogens 
http://dx.doi.org/10.1289/ehp.1104755
Camargo et al. (2011) published the most 
complete meta-analysis on asbestos and ovar-
ian cancer, concluding that “Our study sup-
ports the IARC [International Agency for 
Research on Cancer] conclusion that expo-
sure to asbestos is associated with increased 
risk of ovarian cancer.” Imagine if it had not! 
The IARC Monograph Working 
Group met in 2009 (Straif et al. 2009), but 
the working group, which included four 
authors of the Carmargo et al. (2011) paper, 
apparently did not make use of a formal meta-
analysis of all available studies to evaluate the 
evidence. Although the IARC Monographs staff 
have occasionally conducted meta-analyses 
prior to a monograph (e.g., Guha et al. 
2009), formal meta-analyses are not prepared 
routinely for the evaluations. However, such 
meta-analyses can be considered when they 
are publicly available and, as stated in the 
“Preamble to the IARC Monographs,” “ad-hoc 
calculations that combine data from different 
studies may be conducted by the Working 
Group during the course of a Monograph 
meeting” (IARC 2012).
Although meta-analyses have been widely 
used in social sciences and medical research 
for decades, it is only recently that they have 
become more widely used in epidemiology 
(Greenland and O’Rourke 2008), and they 
were not widely used at the time that the IARC 
Monograph procedures were first developed. As 
Greenland and O’Rourke (2008) comment, 
Epidemiologic studies of specific topics have 
tended to be fewer [than is the case in social 
science or medicine], and the epidemiologic 
community appears to be more hospitable to 
tentative, limited inferences based on narrative 
reviews. Nonetheless, to neglect quantitative 
aspects of review would be akin to presenting a 
study and supplying only a narrative discussion 
of the raw data, with no attempt to group and 
compare subject outcomes.
Having participated in several Monograph 
Working Groups, we know that informal 
meta-analyses are performed by members 
of the working groups (at least by ourselves) 
because this is one of the standard ways to 
quantitatively summarize the evidence. Meta-
analyses can be challenging and controversial 
depending on assumptions, particularly for 
studies on occupational and environmental 
exposures that frequently are not easy to 
quantify. Certainly meta-analy ses cannot be 
done for all agents evaluated by IARC, and 
results of meta-analyses have to be critically 
interpreted in a manner similar to that of all 
other data. 
Even without using formal procedures 
for a quantitative summary of the epidemio-
logical evidence, IARC Working Groups 
reach conclusions that are seldom seriously 
challenged, particularly for Group 1 
carcinogens. This is probably because 
IARC Working Groups tend to express the 
consensus in the scientific world. When 
they occasionally have made controversial 
decisions, for example the 1997 dioxin 
evaluation reclassifying TCDD from a 
Group 2B (possible) carcinogen to Group 1, 
they seem to have been proven right by later 
research. IARC has revised procedures for the 
Monographs evalua tions, incorporating the 
systematic inclusion of biological knowledge 
into the criteria for the classifications, and 
has also updated the whole process for other 
items, such as conflict of interest and the 
prodecure for the selection of participants. 
These changes have strengthened the validity 
and acceptance of these evaluations. Given 
the international importance of the IARC 
Monographs, it seems advisable to use all the 
tools available for summarizing the scientific 
evidence, one of which is meta-analysis. 
The meta-analysis by Camargo et al. (2011) 
clearly demon strates this regarding both the 
overall meta-estimate that is not negligible 
(standardized mortality ratio of around 1.8) 
and the discussion of the hetero geneity of the 
findings between studies that can be formally 
examined in a meta-analysis. If we had been 
members of that Working Group, we would 
certainly have preferred to have this meta-
analysis on hand before doing the evaluation.
The authors declare they have no actual or 
potential competing financial interests.
Manolis Kogevinas 
Centre for Research in Environmental 
Epidemiology (CREAL)
Barcelona, Spain
E-mail: kogevinas@creal.cat
Neil Pearce 
Faculty of Epidemiology and Public Health
London School of Hygiene and 
Tropical Medicine
London, United Kingdom
RefeRences
Camargo MC, Stayner LT, Straif K, Reina M, Al-Alem U, 
Demers PA, et al. 2011. Occupational exposure to asbes-
tos and ovarian cancer: a meta-analysis. Environ Health 
Perspect 119:1211–1217.
Greenland S, O’Rourke K. 2008. Meta-analysis. In: Modern 
Epidemiology (Rothman KJ, Greenland S, Lash TL, eds). 
3rd ed. Philadelphia:Lippincott Williams, 652–682. 
Guha N, Merletti F, Steenland NK, Altieri A, Cogliano V, Straif K. 
2010. Lung cancer risk in painters: a meta-analysis. 
Environ Health Perspect 118:303–312. 
IARC (International Agency for Research on Cancer). 2012. 
Preamble to the IARC Monographs. Available: http://
monographs.iarc.fr/ENG/Preamble/index.php [accessed 
2 February 2012].
Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, 
El Ghissassi F, et al. 2009. A review of human carcino-
gens—part C: metals, arsenic, dusts, and fibres. Lancet 
Oncol 10:453–454.
Editor’s note: In accordance with journal 
policy, Camargo et al. were asked whether they 
wanted to respond to this letter, but they chose 
not to do so.
Relationship of Creatinine 
and Nutrition with Arsenic 
Metabolism
http://dx.doi.org/10.1289/ehp.1104807
Basu et al. (2011) reported the associations of 
both dietary and blood nutrient measures, as 
well as urinary creatinine (uCr), with arsenic 
(As) methyla tion capacity, as assessed by the 
proportions of urinary inorganic, mono methyl, 
and dimethyl As metabolites. One finding 
was that uCr was the strongest predictor of 
As methylation; participants with higher 
uCr concentrations had a higher percentage 
of total urinary As as dimethylarsinic acid 
(DMA) compared to those with lower 
uCr. This is consistent with what we have 
previously reported in Bangladeshi adults and 
children (Gamble et al. 2005; Ahsan et al. 
2007; Hall et al. 2009), and is an interesting 
and potentially very important observation. 
Approximately 40% of S-adenosylmethionine 
(SAM)-derived methyl groups are devoted to 
the bio synthesis of creatine, the precursor of 
creati nine (Brosnan et al. 2011; Mudd and 
Poole 1975). At high levels of As exposure 
(500–1,000 µg/L), based on one-carbon 
kinetics (Schalinske and Steele 1989), we 
estimated that methyla tion of 80% of a daily 
dose of inorganic As (InAs) to DMA would 
require approximately 50 µmol SAM, thus 
consuming approximately 2–4% of the SAM 
normally turning over in a well-nourished 
adult per day. Low dietary crea tine intake 
associated with low-protein or vegetarian diets 
places an increased demand for SAM for crea-
tine biosynthesis (Brosnan 2011). This could 
potentially reduce the availability of SAM for 
As methylation, providing a plausible mecha-
nism under lying this highly reproducible 
observation. This assumes that uCr reflects, 
to some extent, dietary creatine intake, as 
we have observed (Gamble M, unpublished 
data). Conversely, dietary crea tine intake 
and/or creatine supplementation down-
regulates endogenous creatine bio synthesis, 
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